1. Search Result

Search Result

Results for "936487-67-1" in MCE Product Catalog:

Cat. No. Product Name Target Research Area
  • HY-10220
    SF1126

    PI3K Apoptosis Cancer
    SF1126 is a clinically relevant pan and dual first-in-class PI3K/BRD4 inhibitor, has antitumor and anti-angiogenic activity. SF1126 is an RGDS-conjugated LY294002 prodrug, which is designed to exhibit increased solubility and bind to specific integrins within the tumor compartment. SF1126 induces cell apoptosis.